US Broker Ratings

Benitec Biopharma Inc. (BNTC) Stock Analysis: Exploring a 105.55% Potential Upside in Biotechnology

Benitec Biopharma Inc. (NASDAQ: BNTC), a clinical-stage biotechnology company, is generating significant buzz among investors with its promising pipeline and potential upside. Specializing in the development..

Olema Pharmaceuticals, Inc. (OLMA) Stock Analysis: Exploring a 374% Upside Potential in the Biotech Arena

Olema Pharmaceuticals, Inc. (NASDAQ: OLMA) stands out in the healthcare sector as a promising player in the biotechnology industry, primarily focusing on the development of innovative..

Erasca, Inc. (ERAS) Stock Analysis: Unveiling a Potential 226% Upside in Oncology Innovations

Erasca, Inc. (NASDAQ: ERAS), a trailblazer in the biotechnology sector, is drawing significant attention from investors with its cutting-edge approach to precision oncology. With a market..

Cidara Therapeutics, Inc. (CDTX) Stock Analysis: A Biotech with 26% Upside Potential

Cidara Therapeutics, Inc. (NASDAQ: CDTX), a San Diego-based biotechnology company, is making waves in the healthcare sector with its innovative approach to treating serious diseases, particularly..

Rigel Pharmaceuticals, Inc. (RIGL) Stock Analysis: Strong Revenue Growth and Strategic Partnerships Highlight Potential

Rigel Pharmaceuticals, Inc. (NASDAQ: RIGL) is a biotechnology company focused on developing innovative therapies that address hematologic disorders and cancer. With a market capitalization of $656.15..

TruBridge, Inc. (TBRG) Stock Analysis: Unveiling a 23.69% Potential Upside in Healthcare IT

For investors eyeing the healthcare information technology sector, TruBridge, Inc. (NASDAQ: TBRG) presents an intriguing opportunity. With a market capitalization of $300.38 million, TruBridge operates at..

NANO-X IMAGING LTD (NNOX) Investor Outlook: Unpacking the 70% Potential Upside

Nano-X Imaging Ltd. (NASDAQ: NNOX), an innovative player in the healthcare sector, is gaining traction among investors keen on the medical devices industry. Based in Israel,..

MiMedx Group, Inc. (MDXG) Stock Analysis: Exploring a 73.30% Potential Upside in the Healthcare Biotech Arena

MiMedx Group, Inc. (NASDAQ: MDXG) presents a compelling narrative for investors with its promising growth potential and innovative presence in the healthcare biotechnology sector. Headquartered in..

Harrow, Inc. (HROW) Stock Analysis: A 76% Upside Potential in the Eye of Investors

Harrow, Inc. (HROW) is making waves in the healthcare sector, particularly within the niche of specialty and generic drug manufacturing. With a market capitalization of $1.24..

agilon health, inc. (AGL) Stock Analysis: Can a Potential 144.91% Upside Revitalize Investor Confidence?

agilon health, inc. (NYSE: AGL), a healthcare services provider focused on senior care through primary care physicians, is navigating challenging waters in the medical care facilities..

MannKind Corporation (MNKD) Stock Analysis: Exploring a 170% Upside Potential

MannKind Corporation (MNKD), a U.S.-based biopharmaceutical company, is making waves in the healthcare sector with its focus on developing and commercializing therapeutic products for endocrine and..

NeoGenomics, Inc. (NEO) Stock Analysis: Navigating a 47.96% Potential Upside in the Diagnostics Sector

Investors with a keen interest in the healthcare sector’s diagnostics and research domain might find NeoGenomics, Inc. (NASDAQ: NEO) an intriguing prospect. With a market capitalization..

89bio, Inc. (ETNB) Stock Analysis: Unpacking the 233% Potential Upside in Biotech

89bio, Inc. (NASDAQ: ETNB), a clinical-stage biopharmaceutical company, has been attracting significant attention from investors, particularly due to its substantial potential upside of 233.78%. Specializing in..

Amphastar Pharmaceuticals (AMPH) Stock Analysis: Exploring a Potential 14% Upside Amid Market Dynamics

Amphastar Pharmaceuticals, Inc. (NASDAQ: AMPH), a key player in the healthcare sector, specifically within the specialty and generic drug manufacturing industry, has been capturing investor attention..

Neogen Corporation (NEOG) Stock Analysis: Exploring a 27.2% Potential Upside Amidst Market Challenges

Neogen Corporation (NASDAQ: NEOG), a key player in the healthcare sector specializing in diagnostics and research, presents a complex yet intriguing opportunity for investors. With a..

IDEAYA Biosciences, Inc. (IDYA) Stock Analysis: Unveiling a Potential 106% Upside

For investors navigating the volatile waters of biotechnology, IDEAYA Biosciences, Inc. (NASDAQ: IDYA) emerges as a fascinating prospect. With a market capitalization of $2 billion, this..

AdaptHealth Corp. (AHCO) Stock Analysis: Navigating a 40% Potential Upside in the Healthcare Sector

AdaptHealth Corp. (AHCO) stands as a notable player in the healthcare sector, specifically within the medical devices industry. Headquartered in Plymouth Meeting, Pennsylvania, AdaptHealth specializes in..

Aurinia Pharmaceuticals Inc (AUPH) Stock Analysis: Impressive Revenue Growth and Strong Buy Ratings Signal Promising Potential

Aurinia Pharmaceuticals Inc. (NASDAQ: AUPH), a prominent player in the biotechnology sector, has been capturing investor attention with its recent stock performance and growth potential. Headquartered..

GRAIL, Inc. (GRAL) Stock Report: Analyzing the 23.89% Potential Upside in Healthcare Diagnostics

GRAIL, Inc. (NASDAQ: GRAL) stands at the forefront of innovation in the healthcare sector, carving a niche in the diagnostics and research industry. With a market..

Pulse Biosciences, Inc. (PLSE) Stock Analysis: A Compelling 47.85% Potential Upside Awaits Investors

Pulse Biosciences, Inc. (NASDAQ: PLSE) represents an intriguing opportunity within the healthcare sector, particularly for investors keen on novel medical technologies. As a leader in bioelectric..

US Broker Ratings

US Broker Ratings

FTSE 100

Funds